0

Cardiovascular and Metabolic Disease Center
Mitochondrial Research Affinity Collaboration-Laboratories & Engineering

Home > 0

Edison Pharma, University of Bologna and Columbia University Medical Center Establish Mitochondrial Disease Partnership

  • 작성자한진
  • 작성일2006-03-19 19:41:59
  • 조회수4513
  • 첨부파일첨부파일
SAN JOSE, Calif., BOLOGNA, Italy, and NEW YORK, March 16 /PRNewswire/ -- Edison Pharmaceuticals, the University of Bologna and Columbia University Medical Center announced today a collaboration in the field of inherited mitochondrial diseases. By combining preclinical biology skills and clinical expertise resident at Columbia and Bologna, with translational and drug development competencies of Edison, the integrated team intends to bring forward new therapeutic candidates to treat these diseases. The collaboration will focus on mitochondrial diseases affecting the eye and brain. Redox encrypted pharmacophores identified from Edison's chemistry efforts will be evaluated in unique systems-biology screens established at Columbia and Bologna. The collaboration is set forth to identify new classes of compounds addressing respiratory chain defects associated with inherited mitochondrial diseases, as well as molecular targets and clinical biomarkers. Work performed at Columbia University Medical Center will broadly explore Edison's chemistry for a variety of mitochondrial diseases that share a common mechanism -- defects in electron transfer -- essential for energy metabolism. "There is a growing awareness of the role of mitochondria in disease. In addition to being central in inherited mitochondrial defects, there is substantial evidence linking mitochondrial dysfunction with Parkinson's Disease, brain injury and diabetes," stated Eric Schon, PhD, Lewis P. Rowland Professor of Neurology, Columbia University Medical Center. "This body of research is intended to translate basic biochemical insights into important therapeutic developments relevant not only for inherited mitochondrial diseases, but also for other conditions that share a common mechanism." Complementing work performed at Columbia University Medical Center, investigations conducted at the University of Bologna will more narrowly focus on applications in inherited mitochondrial diseases affecting the eye. "The eye is highly dependent upon energy derived from the mitochondria to perform vital events associated with vision," stated Valerio Carelli, MD, PhD, Associate Professor, Laboratory of Neurogenetics at the Department of Neurological Sciences, University of Bologna. "Initially we will focus on Leber's Hereditary Optic Neuropathy and other inherited mitochondrial diseases with visual manifestations. We expect that the results of our work should not only have broad applications for these diseases, but may find utility in macular degeneration and other retinal diseases." "Edison Pharma is committed to translational initiatives and drug development in orphan mitochondrial diseases," stated Guy Miller, MD, PhD, CEO of Edison. "This partnership is one of several that we will announce, central to forming a critical mass of investigators worldwide to develop drugs for these untreated diseases." About Columbia University Medical Center Columbia University Medical Center provides international leadership in pre-clinical and clinical research, in medical and health sciences education, and in patient care. The medical center trains future leaders in health care and includes the dedicated work of many physicians, scientists, nurses, dentists, and public health professionals at the College of Physicians & Surgeons, the College of Dental Medicine, the School of Nursing, the Mailman School of Public Health, the biomedical departments of the Graduate School of Arts and Sciences, and allied research centers and institutions. Columbia University Medical Center researchers are leading the discovery of novel therapies and advances to address a wide range of health conditions. http://www.cumc.columbia.edu/ About University of Bologna The University of Bologna is recognized as the oldest university in the western world and offers a multi-campus structure, which is divided into 23 faculties, 68 departments and 5 university campus branches within the cities of Bologna, Cesena, Forli, Ravenna and Rimini. Its Department of Neurological Sciences has an international reputation for clinical and biological research in the fields of epilepsy, sleep and neurodegenerative diseases. http://www.neuro.unibo.it/ About Edison Pharmaceuticals Edison Pharmaceuticals, Inc. is focused on the development of drugs to treat energy impairment diseases, also referred to as mitochondrial diseases. The company is advancing into clinical development EPI-A0001 for the treatment of inherited mitochondrial diseases predominately affecting children. Edison's technology platform consists of a specialized knowledge in redox medicinal chemistry which the company believes is essential to drugging key targets contained within mitochondria. Edison will leverage clinical and laboratory data obtained in rare, or orphan, diseases to pursue other conditions that share common mechanisms. The company has obtained substantial non-dilutive peer-reviewed grant support to advance both its pre-clinical and clinical initiatives from foundations including the Muscular Dystrophy Association, Friedreich's Ataxia Research Alliance, and Seek A Miracle. http://www.edisonpharma.com/ Edison Pharmaceuticals, Inc. CONTACT: Ms. Lorraine Gilmore, Manager Administration, of EdisonPharmaceuticals, Inc., +1-408-960-2910 or lgilmore@edisonpharma.com Web site: http://www.edisonpharma.com/
Total405 [ page1/27 ]
No. 제목 작성자 작성일 조회수
405 인제대 의과대학 김형규 교수, 생리학 분야 최고 학술상 수상 2023.11.09 관리자 2023.11.09 44
404 인제대, 과기정통부 ‘2023년도 기초연구실 지원사업’ 선정 2023.09.13 관리자 (web_admin) 2023.09.13 81
403 인제대 교수팀 '돌연사 주범 심부전 원인 규명' 2023.09.13 관리자 (web_admin) 2023.09.13 70
402 2022학년도 인제학술상 수상자 선정 결과 2023.01.05 관리자 2023.01.05 107
401 안전관리 우수연구실 인증 취득 2023.01.05 관리자 2023.01.05 62
400 한진교수 화의자의학상 수상 2023.01.05 관리자 2023.01.05 120
399 이온통로 학회 -Amy 포스터상 수상 2019.01.15 김형규 2019.01.15 2,602
398 센터 겸임교수 조성우 교수 - 한빛사 -JACC Vascular Imaging 2018.12.08 김형규 2018.12.08 2,815
397 2017 IMPACT Symposium 개최 첨부파일 2017.10.31 김보현 2017.10.31 2,602
396 경암바이오유스 2017 첨부파일 2017.08.11 김보현 2017.08.11 2,885
395 KORUS 2017 첨부파일 2017.06.21 김보현 2017.06.21 3,005
394 IMPACT 2016 심포지엄 개최 안내 첨부파일 2016.04.18 관리자 2016.04.18 4,019
393 IMPACT 2015 심포지엄 개최 안내 첨부파일 2015.04.20 서대윤 2015.04.20 2,880
392 2015 중점연구소 성과 전시회 첨부파일 2015.03.31 김형규 2015.03.31 2,472
391 Best Miso Award - 한진 2014.11.04 이정훈 2014.11.04 2,081
처음이전1 2 3 4 5 6 7 8 9 10 다음 마지막